Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2002
Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study
Neyssa M Marina, Debon Cochrane, Elaine Harney, et al.
Plos One
|
November 17, 2015
Imaging Tumor Necrosis with Ferumoxytol
Maryam Aghighi, Daniel Golovko, Celina Ansari, et al.
Pediatric Blood & Cancer
|
April 21, 2015
Racial/ethnic and socioeconomic disparities in survival among children with acute lymphoblastic leukemia in California, 1988-2011: A population-based observational study
Renata Abrahão, Daphne Y Lichtensztajn, Raul C Ribeiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors
Melissa M Hudson, Shesh N Rai, Cesar Nunez, et al.
Radiology
|
March 17, 2016
Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome
Maryam Aghighi, Justin Boe, Jarrett Rosenberg, et al.
Pediatric Blood & Cancer
|
April 30, 2016
Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee
Michael W Bishop, Yu-Chen Chang, Mark D Krailo, et al.
Pediatric Blood & Cancer
|
December 3, 2014
Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group
Daniel M Lerman, Michael J Monument, Elizabeth McIlvaine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2004
Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882
Barbara Cushing, Roger Giller, John W Cullen, et al.
Cardio-Oncology (London, England)
|
March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group
Lisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
Cancer
|
February 22, 2017
Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study
Neyssa M Marina, Qi Liu, Sarah S Donaldson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2002
Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study
Neyssa M Marina, Debon Cochrane, Elaine Harney, et al.
Plos One
|
November 17, 2015
Imaging Tumor Necrosis with Ferumoxytol
Maryam Aghighi, Daniel Golovko, Celina Ansari, et al.
Pediatric Blood & Cancer
|
April 21, 2015
Racial/ethnic and socioeconomic disparities in survival among children with acute lymphoblastic leukemia in California, 1988-2011: A population-based observational study
Renata Abrahão, Daphne Y Lichtensztajn, Raul C Ribeiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors
Melissa M Hudson, Shesh N Rai, Cesar Nunez, et al.
Radiology
|
March 17, 2016
Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome
Maryam Aghighi, Justin Boe, Jarrett Rosenberg, et al.
Pediatric Blood & Cancer
|
April 30, 2016
Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee
Michael W Bishop, Yu-Chen Chang, Mark D Krailo, et al.
Pediatric Blood & Cancer
|
December 3, 2014
Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group
Daniel M Lerman, Michael J Monument, Elizabeth McIlvaine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2004
Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882
Barbara Cushing, Roger Giller, John W Cullen, et al.
Cardio-Oncology (London, England)
|
March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group
Lisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
Cancer
|
February 22, 2017
Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study
Neyssa M Marina, Qi Liu, Sarah S Donaldson, et al.
Page
of 2